These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 33831779)

  • 21. Current progresses of novel natural products and their derivatives/ analogs as anti-Alzheimer candidates: an update.
    Fang L; Gou S; Fang X; Cheng L; Fleck C
    Mini Rev Med Chem; 2013 May; 13(6):870-87. PubMed ID: 23305400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitegnoside Mitigates Neuronal Injury, Mitochondrial Apoptosis, and Inflammation in an Alzheimer's Disease Cell Model via the p38 MAPK/JNK Pathway.
    Wang Q; Jiang H; Wang L; Yi H; Li Z; Liu R
    J Alzheimers Dis; 2019; 72(1):199-214. PubMed ID: 31561371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial abnormalities in Parkinson's disease and Alzheimer's disease: can mitochondria be targeted therapeutically?
    Macdonald R; Barnes K; Hastings C; Mortiboys H
    Biochem Soc Trans; 2018 Aug; 46(4):891-909. PubMed ID: 30026371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Donepezil attenuates Aβ-associated mitochondrial dysfunction and reduces mitochondrial Aβ accumulation in vivo and in vitro.
    Ye CY; Lei Y; Tang XC; Zhang HY
    Neuropharmacology; 2015 Aug; 95():29-36. PubMed ID: 25744714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitochondrial dysfunction--a pharmacological target in Alzheimer's disease.
    Eckert GP; Renner K; Eckert SH; Eckmann J; Hagl S; Abdel-Kader RM; Kurz C; Leuner K; Muller WE
    Mol Neurobiol; 2012 Aug; 46(1):136-50. PubMed ID: 22552779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer's disease.
    Sahoo AK; Dandapat J; Dash UC; Kanhar S
    J Ethnopharmacol; 2018 Apr; 215():42-73. PubMed ID: 29248451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural Bioactive Compounds from Macroalgae and Microalgae for the Treatment of Alzheimer's Disease: A Review.
    Lee JY; Wong CY; Koh RY; Lim CL; Kok YY; Chye SM
    Yale J Biol Med; 2024 Jun; 97(2):205-224. PubMed ID: 38947104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitochondrial therapeutic interventions in Alzheimer's disease.
    Van Giau V; An SSA; Hulme JP
    J Neurol Sci; 2018 Dec; 395():62-70. PubMed ID: 30292965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overview of cannabidiol (CBD) and its analogues: Structures, biological activities, and neuroprotective mechanisms in epilepsy and Alzheimer's disease.
    Li H; Liu Y; Tian D; Tian L; Ju X; Qi L; Wang Y; Liang C
    Eur J Med Chem; 2020 Apr; 192():112163. PubMed ID: 32109623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Increasing Role of Polyphenols as Novel Therapeutics for Alzheimer's: A Review.
    Karim N; Khan H; Khan I; Guo O; Sobarzo-Sánchez E; Rastrelli L; Kamal MA
    Med Chem; 2020; 16(8):1007-1021. PubMed ID: 31702507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and evaluation of 2-(3-arylureido)pyridines and 2-(3-arylureido)pyrazines as potential modulators of Aβ-induced mitochondrial dysfunction in Alzheimer's disease.
    Elkamhawy A; Park JE; Hassan AHE; Pae AN; Lee J; Park BG; Roh EJ
    Eur J Med Chem; 2018 Jan; 144():529-543. PubMed ID: 29288949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotective Effects of Icariin on Brain Metabolism, Mitochondrial Functions, and Cognition in Triple-Transgenic Alzheimer's Disease Mice.
    Chen YJ; Zheng HY; Huang XX; Han SX; Zhang DS; Ni JZ; He XY
    CNS Neurosci Ther; 2016 Jan; 22(1):63-73. PubMed ID: 26584824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Progress of clinical trials in Alzheimer’s disease drugs].
    Peng Y; Li PP; Li L; Zhang Y; Hou WZ; Cui DD; Li J; Wang L; Wang QL; Wang XL
    Yao Xue Xue Bao; 2016 Aug; 51(8):1185-95. PubMed ID: 29897711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is it All Said for NSAIDs in Alzheimer's Disease? Role of Mitochondrial Calcium Uptake.
    Sanz-Blasco S; Calvo-Rodriguez M; Caballero E; Garcia-Durillo M; Nunez L; Villalobos C
    Curr Alzheimer Res; 2018; 15(6):504-510. PubMed ID: 29283047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural products as a rich source of tau-targeting drugs for Alzheimer's disease.
    Calcul L; Zhang B; Jinwal UK; Dickey CA; Baker BJ
    Future Med Chem; 2012 Sep; 4(13):1751-61. PubMed ID: 22924511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multi-potent Natural Scaffolds Targeting Amyloid Cascade: In Search of Alzheimer's Disease Therapeutics.
    Chakraborty S
    Curr Top Med Chem; 2017; 17(31):3336-3348. PubMed ID: 29345580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands.
    Iraji A; Khoshneviszadeh M; Firuzi O; Khoshneviszadeh M; Edraki N
    Bioorg Chem; 2020 Apr; 97():103649. PubMed ID: 32101780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotective effect of natural products against Alzheimer's disease.
    Essa MM; Vijayan RK; Castellano-Gonzalez G; Memon MA; Braidy N; Guillemin GJ
    Neurochem Res; 2012 Sep; 37(9):1829-42. PubMed ID: 22614926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent trends of natural based therapeutics for mitochondria targeting in Alzheimer's disease.
    Dhiman A; Handa M; Ruwali M; Singh DP; Kesharwani P; Shukla R
    Mitochondrion; 2022 May; 64():112-124. PubMed ID: 35367397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.